PPT-Fixed-Dose Combination of

Doravirine LamivudineTDF is NonInferior to Efavirenz Emtricitabine TDF in TreatmentNaïve Adults With HIV1 Infection Week 48 Results of the Phase 3 DRIVEAHEAD Study Kathleen E Squires. Use of licensed combination vaccines is generally preferred to separate injections of the ir equivalent component vaccines When administering combination vaccines the minimum age for administration is the oldest age f or any of the individual compon TIPS TO GAIN CONTROL. HTN Burden of Disease. Importance of Appropriate HTN Treatment. Case Study: Michael. Case Study: Michael (cont). Potential Reasons for Uncontrolled BP in Michael. Case Study: Michael (cont). Program Goals. Complementary Mechanism of Action . . DPP-4 Inhibitors SGLT2 Inhibitors . Clinical Pearls. Fixed-Dose Combination Therapies. Using Fixed-Dose Combination Therapies to Achieve HbA. 1c. Pain management. By Roshni Guerry, MD. Supportive and Palliative Care Inpatient Medical Director. Objectives. Describe four classifications of opioids. . and their preferred indications. List which opioids are preferred for renal and liver patients. Insulin and Incretins: the perfect Partnership? Stephen Colagiuri, MD Professor of Metabolic Health Boden Institute of Obesity, Nutrition and Exercise University of Sydney Sydney, Australia Moderator to . Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib, and . Low. -Dose Dexamethasone in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma. Richardson PG et . December 7-9, 2015 Atlanta . Ga. Symposium on Anti-HIV Drug Combination Strategies. December 9. th. , 2015 9-10AM. Chair by Ting-Chao Chou & M. . Intakhab. . Alam. 1. 2. Computerized Simulation of Anti-HIV Drug. in . Networks . of . Interventions. ?. Areti . Angeliki. Veroniki, MSc, PhD. Prepared for. : 2015 . CADTH . Symposium. April 14, 2015. Knowledge . Translation . Li . Ka. . Shing. Knowledge . Institute. Myeloma. 1. Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple . Myeloma. 2. 1 . Martin TG et al.. Proc. ASH . 2014;Abstract 83.. 2 . had . Comparable Immunological. , . Virological. . and . Adherence Potential . with . Single Drug . C. ombinations. Avong . YK. 1. , . Jatau. B. 1. , . . Ekong. E. 1. , Ndembi N. 1. , Okuma J. 1. WHO Essential Medicines List & Why It Matters. Global Burden of Hypertension & Key Gaps. Rationale for Fixed Dose Combinations (FDC) for Hypertension as an Essential Medicine. Guidelines. Efficacy . Crizotinib. (. cMET. inhibitor) Combined . with . Binimetinib. (MEK1/2 inhibitor) in Patients with Advanced Solid Tumours. Wilson RH. 1,2. , Hari . Dass. P. 10. , Van Schaeybroeck S. 1,2. , . Rolfo. 1. ViiV Healthcare, Brentford, UK; . 2. Centre Hospitalier de Tourcoing, Tourcoing, France; . 3. Holdsworth House Medical Brisbane, Queensland, Australia; . 4. CHU Saint-Pierre, Brussels, Belgium; . 5. +. Peripheral T-Cell Lymphoma: A Phase 2 Study (LuminICE-203). Alison Moskowitz. 1. , Andreas Harstrick. 2. , Michael Emig. 2. , Andre Overesch. 2. ,. . Sheena Pinto. 2. , . Paulien Ravenstijn. 2.